Current status and prospects of immunotherapy in esophageal cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 502-505, 2018.
Artigo
em Chinês
| WPRIM
| ID: wpr-693543
ABSTRACT
The treatment of esophageal cancer is difficult in clinic.Recently,the development of immune checkpoint inhibitors has brought the immunotherapies to a new age.In predicting the curative effect of biomarkers,programmed cell death-ligand 1,tumor mutation burden and microsatellite instability could promisingly predict the effect of the immune checkpoint inhibitors.Various immune checkpoint inhibitors are emerging and the combination of immunotherapy have shown a great applied potential in a series of clinical trials of esophageal cancer.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of International Oncology
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS